

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.24202864 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.24202864 |
| 3 | neutrophil activation involved in immune response (GO:0002283) | 6.05813423 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 5.96320587 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.96320587 |
| 6 | cysteine metabolic process (GO:0006534) | 5.74138957 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.40000294 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 5.26564357 |
| 9 | sulfur amino acid catabolic process (GO:0000098) | 4.98186799 |
| 10 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.97501618 |
| 11 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.87845017 |
| 12 | negative regulation of cell killing (GO:0031342) | 4.87845017 |
| 13 | glyoxylate metabolic process (GO:0046487) | 4.78051103 |
| 14 | bile acid biosynthetic process (GO:0006699) | 4.64282657 |
| 15 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.56436603 |
| 16 | alpha-linolenic acid metabolic process (GO:0036109) | 4.55111975 |
| 17 | tryptophan catabolic process (GO:0006569) | 4.53528386 |
| 18 | indole-containing compound catabolic process (GO:0042436) | 4.53528386 |
| 19 | indolalkylamine catabolic process (GO:0046218) | 4.53528386 |
| 20 | neutrophil activation (GO:0042119) | 4.48495455 |
| 21 | tryptophan metabolic process (GO:0006568) | 4.47105478 |
| 22 | positive regulation by symbiont of host defense response (GO:0052509) | 4.44437490 |
| 23 | modulation by symbiont of host defense response (GO:0052031) | 4.44437490 |
| 24 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.44437490 |
| 25 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.44437490 |
| 26 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.44437490 |
| 27 | modulation by symbiont of host immune response (GO:0052553) | 4.44437490 |
| 28 | serine family amino acid catabolic process (GO:0009071) | 4.40218132 |
| 29 | urea cycle (GO:0000050) | 4.36423519 |
| 30 | urea metabolic process (GO:0019627) | 4.36423519 |
| 31 | protein carboxylation (GO:0018214) | 4.33867256 |
| 32 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.33867256 |
| 33 | kynurenine metabolic process (GO:0070189) | 4.27519026 |
| 34 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.23178565 |
| 35 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.23094321 |
| 36 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.19009739 |
| 37 | urate metabolic process (GO:0046415) | 4.17975807 |
| 38 | heme transport (GO:0015886) | 4.12294661 |
| 39 | nitrogen cycle metabolic process (GO:0071941) | 4.05833849 |
| 40 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.03389906 |
| 41 | aromatic amino acid family metabolic process (GO:0009072) | 4.03184636 |
| 42 | regulation of protein activation cascade (GO:2000257) | 4.00704887 |
| 43 | complement activation, alternative pathway (GO:0006957) | 3.99892369 |
| 44 | bile acid metabolic process (GO:0008206) | 3.99134370 |
| 45 | serine family amino acid metabolic process (GO:0009069) | 3.96107444 |
| 46 | detection of other organism (GO:0098543) | 3.95277826 |
| 47 | positive regulation of mast cell activation (GO:0033005) | 3.94126417 |
| 48 | negative regulation of fibrinolysis (GO:0051918) | 3.93374135 |
| 49 | granulocyte activation (GO:0036230) | 3.89768750 |
| 50 | lysine metabolic process (GO:0006553) | 3.84332157 |
| 51 | lysine catabolic process (GO:0006554) | 3.84332157 |
| 52 | amino-acid betaine metabolic process (GO:0006577) | 3.83277550 |
| 53 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.82991546 |
| 54 | tyrosine metabolic process (GO:0006570) | 3.80339850 |
| 55 | regulation of complement activation (GO:0030449) | 3.80324669 |
| 56 | high-density lipoprotein particle remodeling (GO:0034375) | 3.79642247 |
| 57 | regulation of platelet aggregation (GO:0090330) | 3.78607227 |
| 58 | homocysteine metabolic process (GO:0050667) | 3.78483749 |
| 59 | macrophage activation involved in immune response (GO:0002281) | 3.76291230 |
| 60 | ethanol oxidation (GO:0006069) | 3.73664493 |
| 61 | aldehyde catabolic process (GO:0046185) | 3.73163744 |
| 62 | detection of bacterium (GO:0016045) | 3.72922934 |
| 63 | regulation of triglyceride catabolic process (GO:0010896) | 3.67793761 |
| 64 | serine family amino acid biosynthetic process (GO:0009070) | 3.66908552 |
| 65 | microglial cell activation (GO:0001774) | 3.65701330 |
| 66 | glycine metabolic process (GO:0006544) | 3.64922706 |
| 67 | regulation of fibrinolysis (GO:0051917) | 3.61173758 |
| 68 | cellular extravasation (GO:0045123) | 3.61096493 |
| 69 | alpha-amino acid catabolic process (GO:1901606) | 3.60962725 |
| 70 | detection of molecule of bacterial origin (GO:0032490) | 3.60931887 |
| 71 | plasma lipoprotein particle clearance (GO:0034381) | 3.58534658 |
| 72 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.56362742 |
| 73 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.55030051 |
| 74 | detection of external biotic stimulus (GO:0098581) | 3.51059355 |
| 75 | triglyceride homeostasis (GO:0070328) | 3.50284627 |
| 76 | acylglycerol homeostasis (GO:0055090) | 3.50284627 |
| 77 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.47842214 |
| 78 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.45479508 |
| 79 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.45479508 |
| 80 | bile acid and bile salt transport (GO:0015721) | 3.44720218 |
| 81 | fibrinolysis (GO:0042730) | 3.44619258 |
| 82 | cellular amino acid catabolic process (GO:0009063) | 3.44498605 |
| 83 | thrombin receptor signaling pathway (GO:0070493) | 3.43352180 |
| 84 | drug transmembrane transport (GO:0006855) | 3.40132702 |
| 85 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.38098416 |
| 86 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.38098416 |
| 87 | coenzyme catabolic process (GO:0009109) | 3.37987088 |
| 88 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.33997492 |
| 89 | arginine metabolic process (GO:0006525) | 3.33888000 |
| 90 | regulation of mast cell degranulation (GO:0043304) | 3.33886387 |
| 91 | cellular modified amino acid catabolic process (GO:0042219) | 3.33756460 |
| 92 | reverse cholesterol transport (GO:0043691) | 3.30640466 |
| 93 | response to host immune response (GO:0052572) | 3.29471262 |
| 94 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.29471262 |
| 95 | cellular ketone body metabolic process (GO:0046950) | 3.29291597 |
| 96 | drug catabolic process (GO:0042737) | 3.27854038 |
| 97 | regulation of gamma-delta T cell activation (GO:0046643) | 3.26880152 |
| 98 | negative regulation of sterol transport (GO:0032372) | 3.25775655 |
| 99 | negative regulation of cholesterol transport (GO:0032375) | 3.25775655 |
| 100 | indolalkylamine metabolic process (GO:0006586) | 3.23366340 |
| 101 | cholesterol homeostasis (GO:0042632) | 3.22118888 |
| 102 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.20525053 |
| 103 | fatty acid oxidation (GO:0019395) | 3.20489952 |
| 104 | myeloid cell activation involved in immune response (GO:0002275) | 3.19853524 |
| 105 | macrophage activation (GO:0042116) | 3.19046642 |
| 106 | response to peptidoglycan (GO:0032494) | 3.18358477 |
| 107 | protein-lipid complex remodeling (GO:0034368) | 3.17646802 |
| 108 | macromolecular complex remodeling (GO:0034367) | 3.17646802 |
| 109 | plasma lipoprotein particle remodeling (GO:0034369) | 3.17646802 |
| 110 | sterol homeostasis (GO:0055092) | 3.17169093 |
| 111 | fatty acid beta-oxidation (GO:0006635) | 3.16614704 |
| 112 | ethanol metabolic process (GO:0006067) | 3.16296370 |
| 113 | carboxylic acid catabolic process (GO:0046395) | 3.16240591 |
| 114 | organic acid catabolic process (GO:0016054) | 3.16240591 |
| 115 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.16221634 |
| 116 | regulation of mast cell activation (GO:0033003) | 3.14635717 |
| 117 | drug transport (GO:0015893) | 3.14629104 |
| 118 | amine catabolic process (GO:0009310) | 3.13857692 |
| 119 | cellular biogenic amine catabolic process (GO:0042402) | 3.13857692 |
| 120 | lipid oxidation (GO:0034440) | 3.13811377 |
| 121 | cofactor catabolic process (GO:0051187) | 3.13733019 |
| 122 | response to mercury ion (GO:0046689) | 3.12435748 |
| 123 | regulation of cholesterol homeostasis (GO:2000188) | 3.11323315 |
| 124 | regulation of platelet activation (GO:0010543) | 3.10845557 |
| 125 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.09870643 |
| 126 | cholesterol efflux (GO:0033344) | 3.09416479 |
| 127 | leukocyte aggregation (GO:0070486) | 3.08848129 |
| 128 | benzene-containing compound metabolic process (GO:0042537) | 3.08682564 |
| 129 | regulation of cholesterol esterification (GO:0010872) | 3.07354067 |
| 130 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.06816245 |
| 131 | primary alcohol catabolic process (GO:0034310) | 3.05034297 |
| 132 | fatty acid catabolic process (GO:0009062) | 3.04980576 |
| 133 | sulfur amino acid metabolic process (GO:0000096) | 3.04402628 |
| 134 | phospholipid efflux (GO:0033700) | 3.04142542 |
| 135 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.04026572 |
| 136 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.03373849 |
| 137 | acetyl-CoA metabolic process (GO:0006084) | 3.03233992 |
| 138 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.02572288 |
| 139 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.01218928 |
| 140 | response to host (GO:0075136) | 3.01218928 |
| 141 | response to host defenses (GO:0052200) | 3.01218928 |
| 142 | response to interleukin-15 (GO:0070672) | 2.99978900 |
| 143 | leukocyte degranulation (GO:0043299) | 2.99258586 |
| 144 | very long-chain fatty acid metabolic process (GO:0000038) | 2.98579642 |
| 145 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.98531592 |
| 146 | short-chain fatty acid metabolic process (GO:0046459) | 2.97766451 |
| 147 | branched-chain amino acid catabolic process (GO:0009083) | 2.96838002 |
| 148 | detection of biotic stimulus (GO:0009595) | 2.96143147 |
| 149 | regulation of cholesterol metabolic process (GO:0090181) | 2.95628858 |
| 150 | pantothenate metabolic process (GO:0015939) | 2.95591134 |
| 151 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.94381807 |
| 152 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.93837548 |
| 153 | regulation of leukocyte degranulation (GO:0043300) | 2.93712474 |
| 154 | monocarboxylic acid catabolic process (GO:0072329) | 2.93412323 |
| 155 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.93059722 |
| 156 | response to nitrosative stress (GO:0051409) | 2.92460378 |
| 157 | regulation of bile acid biosynthetic process (GO:0070857) | 2.91562694 |
| 158 | cellular glucuronidation (GO:0052695) | 2.90941357 |
| 159 | actin filament polymerization (GO:0030041) | 2.90343256 |
| 160 | intestinal cholesterol absorption (GO:0030299) | 2.88914810 |
| 161 | regulation of regulatory T cell differentiation (GO:0045589) | 2.88689626 |
| 162 | blood coagulation, intrinsic pathway (GO:0007597) | 2.88075930 |
| 163 | ketone body metabolic process (GO:1902224) | 2.86646733 |
| 164 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.85997116 |
| 165 | respiratory burst (GO:0045730) | 2.85307364 |
| 166 | neutrophil mediated immunity (GO:0002446) | 2.84397702 |
| 167 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.84235085 |
| 168 | dendritic cell chemotaxis (GO:0002407) | 2.83304300 |
| 169 | dendritic cell migration (GO:0036336) | 2.79687936 |
| 170 | positive regulation of granulocyte differentiation (GO:0030854) | 2.78990856 |
| 171 | megakaryocyte development (GO:0035855) | 2.76395314 |
| 172 | positive regulation of mast cell degranulation (GO:0043306) | 2.76254923 |
| 173 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.76254923 |
| 174 | adenosine receptor signaling pathway (GO:0001973) | 2.70075412 |
| 175 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.66447704 |
| 176 | regulation of regulated secretory pathway (GO:1903305) | 2.64245706 |
| 177 | negative regulation of interleukin-12 production (GO:0032695) | 2.62692984 |
| 178 | positive regulation of receptor recycling (GO:0001921) | 2.62613270 |
| 179 | cellular response to interleukin-15 (GO:0071350) | 2.60886798 |
| 180 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.59634420 |
| 181 | immunoglobulin mediated immune response (GO:0016064) | 2.59556803 |
| 182 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.58891707 |
| 183 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.57143727 |
| 184 | B cell receptor signaling pathway (GO:0050853) | 2.52628468 |
| 185 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.51987971 |
| 186 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.51987971 |
| 187 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.50909086 |
| 188 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.50290704 |
| 189 | regulation of memory T cell differentiation (GO:0043380) | 2.49841820 |
| 190 | angiogenesis involved in wound healing (GO:0060055) | 2.48225769 |
| 191 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.48198968 |
| 192 | negative regulation of T cell mediated immunity (GO:0002710) | 2.47967051 |
| 193 | germinal center formation (GO:0002467) | 2.45722927 |
| 194 | lipoxygenase pathway (GO:0019372) | 2.44581366 |
| 195 | activated T cell proliferation (GO:0050798) | 2.42618711 |
| 196 | platelet aggregation (GO:0070527) | 2.42546375 |
| 197 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.37565479 |
| 198 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.36223024 |
| 199 | positive regulation of regulated secretory pathway (GO:1903307) | 2.34676474 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.19233040 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.69458184 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.04832241 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.81538404 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.29906124 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.81680085 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.77614479 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.76439737 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.36264510 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.13944462 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.95974505 |
| 12 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.56312207 |
| 13 | SPI1_23127762_ChIP-Seq_K562_Human | 2.54742348 |
| 14 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.45603119 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.31988003 |
| 16 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.31569182 |
| 17 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.29946722 |
| 18 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.23221123 |
| 19 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.14408221 |
| 20 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.06879327 |
| 21 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.06098718 |
| 22 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.01157653 |
| 23 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.00269770 |
| 24 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.93369288 |
| 25 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.90800539 |
| 26 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.85959880 |
| 27 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.84012318 |
| 28 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.83635385 |
| 29 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.75181340 |
| 30 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.74145767 |
| 31 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.73896718 |
| 32 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.67685693 |
| 33 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.66403040 |
| 34 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.63517085 |
| 35 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.61548640 |
| 36 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.59599580 |
| 37 | GATA1_22025678_ChIP-Seq_K562_Human | 1.59402570 |
| 38 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.50755235 |
| 39 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.49788441 |
| 40 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.49343955 |
| 41 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.47459369 |
| 42 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.41077594 |
| 43 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.40405011 |
| 44 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.39800231 |
| 45 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.39540087 |
| 46 | MAF_26560356_Chip-Seq_TH1_Human | 1.39414514 |
| 47 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.39204148 |
| 48 | MYB_26560356_Chip-Seq_TH2_Human | 1.37675304 |
| 49 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.37479504 |
| 50 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.36166743 |
| 51 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.35635002 |
| 52 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.35101807 |
| 53 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.33813798 |
| 54 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.33629912 |
| 55 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.31720770 |
| 56 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.30710548 |
| 57 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29583955 |
| 58 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.28006261 |
| 59 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.27916139 |
| 60 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.26935811 |
| 61 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.26901029 |
| 62 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.25506116 |
| 63 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.25506116 |
| 64 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.25506116 |
| 65 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.24222296 |
| 66 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.23257251 |
| 67 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.23250272 |
| 68 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.21155538 |
| 69 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15721173 |
| 70 | MYB_26560356_Chip-Seq_TH1_Human | 1.14902584 |
| 71 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.14786170 |
| 72 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.14117252 |
| 73 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.12157193 |
| 74 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09292442 |
| 75 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.09007147 |
| 76 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08642407 |
| 77 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.08323201 |
| 78 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.07123794 |
| 79 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.05904700 |
| 80 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.05902417 |
| 81 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.05505679 |
| 82 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.05250015 |
| 83 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.04742286 |
| 84 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.03777302 |
| 85 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.02399042 |
| 86 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99936283 |
| 87 | GATA3_26560356_Chip-Seq_TH2_Human | 0.99423470 |
| 88 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.99230801 |
| 89 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.98016264 |
| 90 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.97867753 |
| 91 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.96490240 |
| 92 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.95930606 |
| 93 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.94967201 |
| 94 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.92706782 |
| 95 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.92336639 |
| 96 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.92252535 |
| 97 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92240434 |
| 98 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.91870459 |
| 99 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.91188987 |
| 100 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.90829527 |
| 101 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.90418326 |
| 102 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.90272892 |
| 103 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.89818154 |
| 104 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.89748410 |
| 105 | * MAF_26560356_Chip-Seq_TH2_Human | 0.89549317 |
| 106 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.88535272 |
| 107 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.87989071 |
| 108 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87146429 |
| 109 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.87021218 |
| 110 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86691066 |
| 111 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86604006 |
| 112 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.86272267 |
| 113 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.85980598 |
| 114 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.85922786 |
| 115 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.85634578 |
| 116 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.85039113 |
| 117 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.84837245 |
| 118 | GATA1_19941826_ChIP-Seq_K562_Human | 0.84279450 |
| 119 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.83879890 |
| 120 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.83718937 |
| 121 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.83553622 |
| 122 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.83520542 |
| 123 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.83449179 |
| 124 | ATF3_27146783_Chip-Seq_COLON_Human | 0.83282306 |
| 125 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.82656281 |
| 126 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.82601343 |
| 127 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.81413024 |
| 128 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.79802701 |
| 129 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.79751196 |
| 130 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.79600964 |
| 131 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.79480402 |
| 132 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.78670965 |
| 133 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.78650123 |
| 134 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.78022717 |
| 135 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.77695580 |
| 136 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.76516250 |
| 137 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.75395166 |
| 138 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.74631713 |
| 139 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.74188697 |
| 140 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.74054852 |
| 141 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.73105231 |
| 142 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.72996037 |
| 143 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.72990217 |
| 144 | GATA2_19941826_ChIP-Seq_K562_Human | 0.72697515 |
| 145 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.72582217 |
| 146 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.72518981 |
| 147 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.72348489 |
| 148 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.72210536 |
| 149 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.72127339 |
| 150 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.72090412 |
| 151 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.71456085 |
| 152 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.71119992 |
| 153 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.70897904 |
| 154 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.70793047 |
| 155 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.70639964 |
| 156 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.69484068 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.01167261 |
| 2 | MP0005360_urolithiasis | 5.51203627 |
| 3 | MP0005365_abnormal_bile_salt | 4.72556846 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.61069529 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.79604296 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.75723939 |
| 7 | MP0009840_abnormal_foam_cell | 3.45719808 |
| 8 | MP0003303_peritoneal_inflammation | 3.22611417 |
| 9 | MP0001835_abnormal_antigen_presentation | 2.85333924 |
| 10 | MP0005451_abnormal_body_composition | 2.81471990 |
| 11 | MP0005083_abnormal_biliary_tract | 2.79767923 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.62854450 |
| 13 | MP0008004_abnormal_stomach_pH | 2.62312908 |
| 14 | MP0003252_abnormal_bile_duct | 2.59433071 |
| 15 | MP0005408_hypopigmentation | 2.56662014 |
| 16 | MP0004510_myositis | 2.56107955 |
| 17 | MP0001666_abnormal_nutrient_absorption | 2.49622763 |
| 18 | MP0005332_abnormal_amino_acid | 2.43721328 |
| 19 | MP0003195_calcinosis | 2.37610376 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 2.33122996 |
| 21 | MP0003828_pulmonary_edema | 2.13609509 |
| 22 | MP0005000_abnormal_immune_tolerance | 2.11535233 |
| 23 | MP0003300_gastrointestinal_ulcer | 2.07643205 |
| 24 | MP0005671_abnormal_response_to | 2.07150207 |
| 25 | MP0002138_abnormal_hepatobiliary_system | 2.04568794 |
| 26 | MP0001800_abnormal_humoral_immune | 2.02801317 |
| 27 | MP0001790_abnormal_immune_system | 1.95798853 |
| 28 | MP0005387_immune_system_phenotype | 1.95798853 |
| 29 | MP0002723_abnormal_immune_serum | 1.90939873 |
| 30 | MP0003172_abnormal_lysosome_physiology | 1.87833705 |
| 31 | MP0003186_abnormal_redox_activity | 1.85871342 |
| 32 | MP0000609_abnormal_liver_physiology | 1.83530853 |
| 33 | MP0003656_abnormal_erythrocyte_physiolo | 1.82348851 |
| 34 | MP0004019_abnormal_vitamin_homeostasis | 1.80706718 |
| 35 | MP0002420_abnormal_adaptive_immunity | 1.77978752 |
| 36 | MP0000685_abnormal_immune_system | 1.77876526 |
| 37 | MP0001819_abnormal_immune_cell | 1.75703904 |
| 38 | MP0002118_abnormal_lipid_homeostasis | 1.75679749 |
| 39 | MP0002452_abnormal_antigen_presenting | 1.74851643 |
| 40 | MP0005058_abnormal_lysosome_morphology | 1.69885965 |
| 41 | MP0003718_maternal_effect | 1.66618282 |
| 42 | MP0003866_abnormal_defecation | 1.64776141 |
| 43 | MP0003868_abnormal_feces_composition | 1.63642081 |
| 44 | MP0002148_abnormal_hypersensitivity_rea | 1.63567330 |
| 45 | MP0010155_abnormal_intestine_physiology | 1.63294719 |
| 46 | MP0003183_abnormal_peptide_metabolism | 1.61354504 |
| 47 | MP0004130_abnormal_muscle_cell | 1.56543295 |
| 48 | MP0005319_abnormal_enzyme/_coenzyme | 1.55619482 |
| 49 | MP0009643_abnormal_urine_homeostasis | 1.55547241 |
| 50 | MP0009697_abnormal_copulation | 1.46588264 |
| 51 | MP0002398_abnormal_bone_marrow | 1.45559880 |
| 52 | MP0001851_eye_inflammation | 1.44381584 |
| 53 | MP0003724_increased_susceptibility_to | 1.43195701 |
| 54 | MP0003436_decreased_susceptibility_to | 1.42981229 |
| 55 | MP0004883_abnormal_blood_vessel | 1.42282671 |
| 56 | MP0000716_abnormal_immune_system | 1.32073948 |
| 57 | MP0003763_abnormal_thymus_physiology | 1.31896568 |
| 58 | MP0010368_abnormal_lymphatic_system | 1.31010298 |
| 59 | MP0002405_respiratory_system_inflammati | 1.29292656 |
| 60 | MP0003045_fibrosis | 1.28977649 |
| 61 | MP0009764_decreased_sensitivity_to | 1.26677689 |
| 62 | MP0001764_abnormal_homeostasis | 1.25862948 |
| 63 | MP0008260_abnormal_autophagy | 1.24423791 |
| 64 | MP0003075_altered_response_to | 1.21345121 |
| 65 | MP0004084_abnormal_cardiac_muscle | 1.19979673 |
| 66 | MP0005636_abnormal_mineral_homeostasis | 1.19780116 |
| 67 | MP0004484_altered_response_of | 1.18410890 |
| 68 | MP0000598_abnormal_liver_morphology | 1.17820897 |
| 69 | MP0000689_abnormal_spleen_morphology | 1.16572980 |
| 70 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.11162601 |
| 71 | MP0002998_abnormal_bone_remodeling | 1.10546340 |
| 72 | MP0002722_abnormal_immune_system | 1.10195221 |
| 73 | MP0002429_abnormal_blood_cell | 1.09440290 |
| 74 | MP0000858_altered_metastatic_potential | 1.08474137 |
| 75 | MP0005647_abnormal_sex_gland | 1.06427387 |
| 76 | MP0004782_abnormal_surfactant_physiolog | 1.05297123 |
| 77 | MP0005395_other_phenotype | 1.04955973 |
| 78 | MP0000465_gastrointestinal_hemorrhage | 1.04309790 |
| 79 | MP0008469_abnormal_protein_level | 1.03574325 |
| 80 | MP0005220_abnormal_exocrine_pancreas | 1.03167735 |
| 81 | MP0009333_abnormal_splenocyte_physiolog | 1.01372635 |
| 82 | MP0005464_abnormal_platelet_physiology | 0.98681613 |
| 83 | MP0004036_abnormal_muscle_relaxation | 0.98160807 |
| 84 | MP0000604_amyloidosis | 0.95947464 |
| 85 | MP0005310_abnormal_salivary_gland | 0.95848803 |
| 86 | MP0009763_increased_sensitivity_to | 0.95481349 |
| 87 | MP0003879_abnormal_hair_cell | 0.95435063 |
| 88 | MP0001756_abnormal_urination | 0.95267981 |
| 89 | MP0008874_decreased_physiological_sensi | 0.93159113 |
| 90 | MP0002098_abnormal_vibrissa_morphology | 0.92601763 |
| 91 | MP0002132_abnormal_respiratory_system | 0.91902099 |
| 92 | MP0005164_abnormal_response_to | 0.91786817 |
| 93 | MP0001765_abnormal_ion_homeostasis | 0.90818094 |
| 94 | MP0005167_abnormal_blood-brain_barrier | 0.89625411 |
| 95 | MP0001663_abnormal_digestive_system | 0.88807159 |
| 96 | MP0009278_abnormal_bone_marrow | 0.87789888 |
| 97 | MP0003453_abnormal_keratinocyte_physiol | 0.87650698 |
| 98 | MP0003705_abnormal_hypodermis_morpholog | 0.87572128 |
| 99 | MP0005670_abnormal_white_adipose | 0.87419734 |
| 100 | MP0005023_abnormal_wound_healing | 0.87000870 |
| 101 | MP0000703_abnormal_thymus_morphology | 0.86806116 |
| 102 | MP0000230_abnormal_systemic_arterial | 0.86271852 |
| 103 | MP0005535_abnormal_body_temperature | 0.85652239 |
| 104 | MP0003011_delayed_dark_adaptation | 0.85265387 |
| 105 | MP0000015_abnormal_ear_pigmentation | 0.84805043 |
| 106 | MP0004147_increased_porphyrin_level | 0.84720785 |
| 107 | MP0002136_abnormal_kidney_physiology | 0.82736263 |
| 108 | MP0005248_abnormal_Harderian_gland | 0.81784909 |
| 109 | MP0004381_abnormal_hair_follicle | 0.79269067 |
| 110 | MP0002254_reproductive_system_inflammat | 0.77916772 |
| 111 | MP0001533_abnormal_skeleton_physiology | 0.77503709 |
| 112 | MP0002796_impaired_skin_barrier | 0.77424243 |
| 113 | MP0006082_CNS_inflammation | 0.75651223 |
| 114 | MP0002419_abnormal_innate_immunity | 0.74630319 |
| 115 | MP0009642_abnormal_blood_homeostasis | 0.74505538 |
| 116 | MP0005409_darkened_coat_color | 0.74170582 |
| 117 | MP0009765_abnormal_xenobiotic_induced | 0.72525654 |
| 118 | MP0000579_abnormal_nail_morphology | 0.71358471 |
| 119 | MP0002166_altered_tumor_susceptibility | 0.68779988 |
| 120 | MP0002693_abnormal_pancreas_physiology | 0.68636710 |
| 121 | MP0005075_abnormal_melanosome_morpholog | 0.68377113 |
| 122 | MP0004264_abnormal_extraembryonic_tissu | 0.68097780 |
| 123 | MP0003690_abnormal_glial_cell | 0.67762576 |
| 124 | MP0000639_abnormal_adrenal_gland | 0.67699174 |
| 125 | MP0002396_abnormal_hematopoietic_system | 0.66619280 |
| 126 | MP0002277_abnormal_respiratory_mucosa | 0.66418884 |
| 127 | MP0001845_abnormal_inflammatory_respons | 0.66109918 |
| 128 | MP0002332_abnormal_exercise_endurance | 0.64058827 |
| 129 | MP0006036_abnormal_mitochondrial_physio | 0.63950867 |
| 130 | MP0001661_extended_life_span | 0.63011107 |
| 131 | MP0002295_abnormal_pulmonary_circulatio | 0.62679817 |
| 132 | MP0005390_skeleton_phenotype | 0.62199169 |
| 133 | MP0005666_abnormal_adipose_tissue | 0.61878384 |
| 134 | MP0002078_abnormal_glucose_homeostasis | 0.61835243 |
| 135 | MP0005084_abnormal_gallbladder_morpholo | 0.60712253 |
| 136 | MP0000462_abnormal_digestive_system | 0.60225214 |
| 137 | MP0009785_altered_susceptibility_to | 0.58450914 |
| 138 | MP0003950_abnormal_plasma_membrane | 0.57970492 |
| 139 | MP0005025_abnormal_response_to | 0.57105320 |
| 140 | MP0000371_diluted_coat_color | 0.56429217 |
| 141 | MP0003566_abnormal_cell_adhesion | 0.56034146 |
| 142 | MP0000343_altered_response_to | 0.55044611 |
| 143 | MP0008873_increased_physiological_sensi | 0.54237138 |
| 144 | MP0004947_skin_inflammation | 0.53927832 |
| 145 | MP0005376_homeostasis/metabolism_phenot | 0.52071859 |
| 146 | MP0002060_abnormal_skin_morphology | 0.52020533 |
| 147 | MP0000249_abnormal_blood_vessel | 0.51741393 |
| 148 | MP0000647_abnormal_sebaceous_gland | 0.51105147 |
| 149 | MP0004185_abnormal_adipocyte_glucose | 0.50934960 |
| 150 | MP0000920_abnormal_myelination | 0.50910697 |
| 151 | MP0003638_abnormal_response/metabolism_ | 0.50323474 |
| 152 | MP0003699_abnormal_female_reproductive | 0.49844845 |
| 153 | MP0000377_abnormal_hair_follicle | 0.49776011 |
| 154 | MP0009931_abnormal_skin_appearance | 0.49216241 |
| 155 | MP0005397_hematopoietic_system_phenotyp | 0.48914571 |
| 156 | MP0001545_abnormal_hematopoietic_system | 0.48914571 |
| 157 | MP0002168_other_aberrant_phenotype | 0.47376961 |
| 158 | MP0005166_decreased_susceptibility_to | 0.47122593 |
| 159 | MP0005501_abnormal_skin_physiology | 0.46890444 |
| 160 | MP0003329_amyloid_beta_deposits | 0.46558368 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged bleeding time (HP:0003010) | 7.66542355 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.21166930 |
| 3 | Petechiae (HP:0000967) | 6.20557607 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.19668102 |
| 5 | Abnormal platelet volume (HP:0011876) | 5.75401438 |
| 6 | Deep venous thrombosis (HP:0002625) | 5.71743858 |
| 7 | Increased mean platelet volume (HP:0011877) | 5.42198742 |
| 8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.36264468 |
| 9 | Xanthomatosis (HP:0000991) | 5.18930596 |
| 10 | Eczematoid dermatitis (HP:0000976) | 5.16680760 |
| 11 | Hyperlipoproteinemia (HP:0010980) | 4.61730116 |
| 12 | Hypobetalipoproteinemia (HP:0003563) | 4.60475170 |
| 13 | Recurrent abscess formation (HP:0002722) | 4.37429704 |
| 14 | Prolonged partial thromboplastin time (HP:0003645) | 4.22201831 |
| 15 | Myositis (HP:0100614) | 4.20438004 |
| 16 | Spontaneous hematomas (HP:0007420) | 4.12997235 |
| 17 | Stomatitis (HP:0010280) | 4.04936581 |
| 18 | Orchitis (HP:0100796) | 4.01748390 |
| 19 | Hyperglycinuria (HP:0003108) | 3.82746606 |
| 20 | Hyperammonemia (HP:0001987) | 3.80595047 |
| 21 | Complement deficiency (HP:0004431) | 3.80156711 |
| 22 | Optic neuritis (HP:0100653) | 3.74668844 |
| 23 | Retrobulbar optic neuritis (HP:0100654) | 3.74668844 |
| 24 | Joint hemorrhage (HP:0005261) | 3.72724148 |
| 25 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.70881279 |
| 26 | Fat malabsorption (HP:0002630) | 3.69724075 |
| 27 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.68986121 |
| 28 | Hyperglycinemia (HP:0002154) | 3.68315108 |
| 29 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.60781999 |
| 30 | Abnormality of glycine metabolism (HP:0010895) | 3.60781999 |
| 31 | Abnormality of the common coagulation pathway (HP:0010990) | 3.55258171 |
| 32 | Hypochromic microcytic anemia (HP:0004840) | 3.50202903 |
| 33 | Hypolipoproteinemia (HP:0010981) | 3.47144077 |
| 34 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.39454615 |
| 35 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.38657236 |
| 36 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.36265973 |
| 37 | Abnormality of methionine metabolism (HP:0010901) | 3.31369888 |
| 38 | Ketosis (HP:0001946) | 3.26893324 |
| 39 | Gastrointestinal infarctions (HP:0005244) | 3.25009801 |
| 40 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.23973118 |
| 41 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.20068268 |
| 42 | Abnormality of the intrinsic pathway (HP:0010989) | 3.19615457 |
| 43 | Abnormal platelet function (HP:0011869) | 3.18986669 |
| 44 | Impaired platelet aggregation (HP:0003540) | 3.18986669 |
| 45 | Steatorrhea (HP:0002570) | 3.18336566 |
| 46 | Gout (HP:0001997) | 3.16450792 |
| 47 | Chronic obstructive pulmonary disease (HP:0006510) | 3.15753961 |
| 48 | Obstructive lung disease (HP:0006536) | 3.15753961 |
| 49 | Generalized aminoaciduria (HP:0002909) | 3.12763817 |
| 50 | Hypoglycemic coma (HP:0001325) | 3.10351689 |
| 51 | Episodic fever (HP:0001954) | 3.03918800 |
| 52 | Encephalitis (HP:0002383) | 3.00749337 |
| 53 | Hypoalphalipoproteinemia (HP:0003233) | 2.99375179 |
| 54 | Epidermoid cyst (HP:0200040) | 2.97897862 |
| 55 | Abnormality of purine metabolism (HP:0004352) | 2.97662122 |
| 56 | Abnormality of nucleobase metabolism (HP:0010932) | 2.93752155 |
| 57 | Hypercholesterolemia (HP:0003124) | 2.89322550 |
| 58 | Chest pain (HP:0100749) | 2.86118524 |
| 59 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.85932221 |
| 60 | Arterial thrombosis (HP:0004420) | 2.85043601 |
| 61 | Recurrent fungal infections (HP:0002841) | 2.75029059 |
| 62 | Esophageal varix (HP:0002040) | 2.73301767 |
| 63 | Abnormality of complement system (HP:0005339) | 2.72705052 |
| 64 | Myocardial infarction (HP:0001658) | 2.72378897 |
| 65 | Increased IgE level (HP:0003212) | 2.70715493 |
| 66 | Recurrent skin infections (HP:0001581) | 2.69227751 |
| 67 | Keratoconjunctivitis sicca (HP:0001097) | 2.66583191 |
| 68 | Hypochromic anemia (HP:0001931) | 2.66429061 |
| 69 | Gingivitis (HP:0000230) | 2.65332724 |
| 70 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.64882827 |
| 71 | Dicarboxylic aciduria (HP:0003215) | 2.64882827 |
| 72 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.61298436 |
| 73 | Bruising susceptibility (HP:0000978) | 2.60615826 |
| 74 | Vascular calcification (HP:0004934) | 2.59880594 |
| 75 | Conjugated hyperbilirubinemia (HP:0002908) | 2.58655220 |
| 76 | Meningitis (HP:0001287) | 2.58151213 |
| 77 | Malnutrition (HP:0004395) | 2.57390459 |
| 78 | Spastic paraparesis (HP:0002313) | 2.53989775 |
| 79 | Metabolic acidosis (HP:0001942) | 2.53770135 |
| 80 | Spastic diplegia (HP:0001264) | 2.52865236 |
| 81 | Ventricular fibrillation (HP:0001663) | 2.51037857 |
| 82 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.49378830 |
| 83 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.48791814 |
| 84 | Keratoconjunctivitis (HP:0001096) | 2.48244118 |
| 85 | Pulmonary embolism (HP:0002204) | 2.48040956 |
| 86 | Abnormality of serum amino acid levels (HP:0003112) | 2.47883692 |
| 87 | Urticaria (HP:0001025) | 2.46870792 |
| 88 | Abnormality of iron homeostasis (HP:0011031) | 2.46334340 |
| 89 | Systemic lupus erythematosus (HP:0002725) | 2.45469568 |
| 90 | Inflammation of the large intestine (HP:0002037) | 2.43492543 |
| 91 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.42437760 |
| 92 | Hyperbilirubinemia (HP:0002904) | 2.41619446 |
| 93 | Increased serum ferritin (HP:0003281) | 2.39983078 |
| 94 | Menorrhagia (HP:0000132) | 2.39963302 |
| 95 | Vasculitis (HP:0002633) | 2.38819814 |
| 96 | Lethargy (HP:0001254) | 2.38628663 |
| 97 | Gingival bleeding (HP:0000225) | 2.38337466 |
| 98 | Vacuolated lymphocytes (HP:0001922) | 2.34160001 |
| 99 | Paraparesis (HP:0002385) | 2.33669005 |
| 100 | Nausea (HP:0002018) | 2.32185878 |
| 101 | Microcytic anemia (HP:0001935) | 2.29456138 |
| 102 | Mediastinal lymphadenopathy (HP:0100721) | 2.28790398 |
| 103 | Gastrointestinal inflammation (HP:0004386) | 2.28529188 |
| 104 | Delayed CNS myelination (HP:0002188) | 2.25554728 |
| 105 | Joint swelling (HP:0001386) | 2.24255174 |
| 106 | Cardiovascular calcification (HP:0011915) | 2.23003677 |
| 107 | Peritonitis (HP:0002586) | 2.22350048 |
| 108 | Vertigo (HP:0002321) | 2.22232469 |
| 109 | Poikilocytosis (HP:0004447) | 2.21717215 |
| 110 | Irritability (HP:0000737) | 2.19718986 |
| 111 | Hepatocellular carcinoma (HP:0001402) | 2.18212704 |
| 112 | Pancreatitis (HP:0001733) | 2.17374789 |
| 113 | Polycythemia (HP:0001901) | 2.17069890 |
| 114 | Axonal loss (HP:0003447) | 2.16475891 |
| 115 | Anorexia (HP:0002039) | 2.14742566 |
| 116 | Spontaneous abortion (HP:0005268) | 2.14394625 |
| 117 | Recurrent cutaneous fungal infections (HP:0011370) | 2.13447671 |
| 118 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.13447671 |
| 119 | Hemorrhage of the eye (HP:0011885) | 2.13447311 |
| 120 | Abnormality of macrophages (HP:0004311) | 2.11583065 |
| 121 | Abnormal pupillary function (HP:0007686) | 2.10951426 |
| 122 | Alkalosis (HP:0001948) | 2.09667196 |
| 123 | Proximal tubulopathy (HP:0000114) | 2.08653010 |
| 124 | Increased IgM level (HP:0003496) | 2.07769354 |
| 125 | Increased purine levels (HP:0004368) | 2.07684640 |
| 126 | Hyperuricemia (HP:0002149) | 2.07684640 |
| 127 | Hepatosplenomegaly (HP:0001433) | 2.05653746 |
| 128 | Testicular neoplasm (HP:0010788) | 2.05476256 |
| 129 | Ketoacidosis (HP:0001993) | 2.03394724 |
| 130 | Opisthotonus (HP:0002179) | 2.02746413 |
| 131 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.02051343 |
| 132 | Acanthocytosis (HP:0001927) | 2.01793804 |
| 133 | Abnormality of urine glucose concentration (HP:0011016) | 2.01726615 |
| 134 | Glycosuria (HP:0003076) | 2.01726615 |
| 135 | Leukocytosis (HP:0001974) | 1.99301434 |
| 136 | Vomiting (HP:0002013) | 1.98491887 |
| 137 | Hemoptysis (HP:0002105) | 1.97932201 |
| 138 | Dysostosis multiplex (HP:0000943) | 1.96956679 |
| 139 | Ileus (HP:0002595) | 1.96553927 |
| 140 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.94431049 |
| 141 | Acute hepatic failure (HP:0006554) | 1.93139420 |
| 142 | Brushfield spots (HP:0001088) | 1.89437095 |
| 143 | Abnormal cartilage morphology (HP:0002763) | 1.87373423 |
| 144 | Glomerulonephritis (HP:0000099) | 1.86951226 |
| 145 | Cellulitis (HP:0100658) | 1.86561663 |
| 146 | Acne (HP:0001061) | 1.85270372 |
| 147 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.85204013 |
| 148 | Pulmonary infiltrates (HP:0002113) | 1.84843527 |
| 149 | Purpura (HP:0000979) | 1.83416365 |
| 150 | Amyloidosis (HP:0011034) | 1.82681983 |
| 151 | Increased cerebral lipofuscin (HP:0011813) | 1.82675798 |
| 152 | T lymphocytopenia (HP:0005403) | 1.82659657 |
| 153 | Gangrene (HP:0100758) | 1.82394194 |
| 154 | Hyporeflexia of lower limbs (HP:0002600) | 1.80557878 |
| 155 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.80385699 |
| 156 | Muscle fibrillation (HP:0010546) | 1.80325808 |
| 157 | Breast hypoplasia (HP:0003187) | 1.79758768 |
| 158 | Abnormality of the endocardium (HP:0004306) | 1.78417898 |
| 159 | Rickets (HP:0002748) | 1.78087404 |
| 160 | Muscle fiber splitting (HP:0003555) | 1.77053799 |
| 161 | Protuberant abdomen (HP:0001538) | 1.74852792 |
| 162 | Abnormality of T cell number (HP:0011839) | 1.73095822 |
| 163 | Hypertriglyceridemia (HP:0002155) | 1.72741490 |
| 164 | Thrombophlebitis (HP:0004418) | 1.72406027 |
| 165 | Hydroxyprolinuria (HP:0003080) | 1.71864591 |
| 166 | Abnormality of proline metabolism (HP:0010907) | 1.71864591 |
| 167 | Recurrent bacterial skin infections (HP:0005406) | 1.70614388 |
| 168 | Pustule (HP:0200039) | 1.69739510 |
| 169 | Skin nodule (HP:0200036) | 1.69362042 |
| 170 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.67698718 |
| 171 | Epistaxis (HP:0000421) | 1.67182810 |
| 172 | Late onset (HP:0003584) | 1.67032506 |
| 173 | Granulocytopenia (HP:0001913) | 1.66789826 |
| 174 | Hypergammaglobulinemia (HP:0010702) | 1.66622359 |
| 175 | Osteomyelitis (HP:0002754) | 1.66616766 |
| 176 | Difficulty running (HP:0009046) | 1.65186764 |
| 177 | Increased density of long bones (HP:0006392) | 1.63306682 |
| 178 | Toxemia of pregnancy (HP:0100603) | 1.62890838 |
| 179 | Increased CSF protein (HP:0002922) | 1.62693462 |
| 180 | Congenital sensorineural hearing impairment (HP:0008527) | 1.61233105 |
| 181 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.57706651 |
| 182 | Colitis (HP:0002583) | 1.55761665 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK19 | 6.74964066 |
| 2 | RIPK4 | 4.92055367 |
| 3 | BCKDK | 4.03717086 |
| 4 | ERN1 | 2.93472496 |
| 5 | TNK2 | 2.58599335 |
| 6 | TAOK3 | 2.53321235 |
| 7 | MAP2K3 | 2.49342021 |
| 8 | BLK | 2.44509329 |
| 9 | ACVR1B | 2.42271675 |
| 10 | ERBB4 | 2.37959424 |
| 11 | AKT3 | 2.28792186 |
| 12 | GRK6 | 2.27523341 |
| 13 | EPHB1 | 2.24891076 |
| 14 | MAP4K1 | 2.19131451 |
| 15 | BTK | 2.10788357 |
| 16 | FES | 2.09789603 |
| 17 | CSK | 2.07896205 |
| 18 | FGFR4 | 1.88767588 |
| 19 | TIE1 | 1.88163473 |
| 20 | MAP3K10 | 1.77336280 |
| 21 | HCK | 1.75940301 |
| 22 | EPHA2 | 1.73466611 |
| 23 | SYK | 1.72531250 |
| 24 | FGR | 1.70789590 |
| 25 | MAP3K6 | 1.64716408 |
| 26 | MET | 1.64544011 |
| 27 | NME2 | 1.60470864 |
| 28 | IRAK3 | 1.59920502 |
| 29 | BMX | 1.59710612 |
| 30 | ABL2 | 1.57996845 |
| 31 | LATS1 | 1.57449680 |
| 32 | PTK2B | 1.55570083 |
| 33 | MST1R | 1.55103799 |
| 34 | TEC | 1.39504767 |
| 35 | EEF2K | 1.39504336 |
| 36 | PLK4 | 1.32229083 |
| 37 | JAK3 | 1.30890099 |
| 38 | MUSK | 1.29211196 |
| 39 | TGFBR1 | 1.28081382 |
| 40 | KDR | 1.26796620 |
| 41 | YES1 | 1.26298699 |
| 42 | BRAF | 1.26241606 |
| 43 | MAPKAPK3 | 1.21698459 |
| 44 | MARK2 | 1.21690247 |
| 45 | MAP3K1 | 1.20232619 |
| 46 | MAP3K11 | 1.19695172 |
| 47 | JAK1 | 1.19255774 |
| 48 | LYN | 1.17103961 |
| 49 | SIK3 | 1.15646005 |
| 50 | PDK1 | 1.12997481 |
| 51 | MAP2K2 | 1.12544645 |
| 52 | TBK1 | 1.12147395 |
| 53 | TXK | 1.10545144 |
| 54 | ITK | 1.10448478 |
| 55 | PDPK1 | 1.07354254 |
| 56 | RIPK1 | 1.05483197 |
| 57 | EPHA3 | 1.05009064 |
| 58 | TTK | 1.01437844 |
| 59 | MAP3K2 | 1.00942188 |
| 60 | MAP3K3 | 1.00751797 |
| 61 | MAPKAPK5 | 1.00236198 |
| 62 | TYK2 | 1.00039159 |
| 63 | MYLK | 0.99891640 |
| 64 | OXSR1 | 0.99798166 |
| 65 | DAPK2 | 0.99293448 |
| 66 | STK39 | 0.97288942 |
| 67 | STK3 | 0.96166624 |
| 68 | PRKD2 | 0.96052795 |
| 69 | BMPR2 | 0.95545052 |
| 70 | TLK1 | 0.94133262 |
| 71 | RPS6KB2 | 0.94116529 |
| 72 | TRIB3 | 0.93924914 |
| 73 | STK10 | 0.92442159 |
| 74 | KSR2 | 0.91910212 |
| 75 | PRPF4B | 0.88146640 |
| 76 | LRRK2 | 0.87099878 |
| 77 | IRAK1 | 0.86847456 |
| 78 | LCK | 0.86112066 |
| 79 | FGFR3 | 0.85907698 |
| 80 | RET | 0.84501674 |
| 81 | SIK1 | 0.83898984 |
| 82 | SGK2 | 0.81749109 |
| 83 | SGK3 | 0.81563774 |
| 84 | PTK6 | 0.79745081 |
| 85 | TAOK1 | 0.79513047 |
| 86 | MAPK11 | 0.78075643 |
| 87 | NEK9 | 0.77716410 |
| 88 | BUB1 | 0.77383409 |
| 89 | FRK | 0.77357979 |
| 90 | HIPK2 | 0.76362955 |
| 91 | MAP3K5 | 0.76221433 |
| 92 | STK4 | 0.76141671 |
| 93 | DYRK1B | 0.75041863 |
| 94 | MAP3K7 | 0.74111999 |
| 95 | MARK3 | 0.73213651 |
| 96 | CSNK1G1 | 0.72988440 |
| 97 | MAP3K8 | 0.72465598 |
| 98 | DYRK3 | 0.72390884 |
| 99 | PIM2 | 0.71799423 |
| 100 | PRKD1 | 0.70453539 |
| 101 | CSNK1G3 | 0.69962719 |
| 102 | MAP2K4 | 0.69192724 |
| 103 | PRKG2 | 0.68437015 |
| 104 | KIT | 0.67844505 |
| 105 | FER | 0.67634044 |
| 106 | PRKAA2 | 0.66734663 |
| 107 | FLT3 | 0.66585882 |
| 108 | FYN | 0.66434448 |
| 109 | PIK3CG | 0.65217476 |
| 110 | PIM1 | 0.63140468 |
| 111 | IKBKB | 0.63045181 |
| 112 | GRK5 | 0.62648948 |
| 113 | ARAF | 0.61905249 |
| 114 | JAK2 | 0.61722624 |
| 115 | TESK2 | 0.61620661 |
| 116 | MAP2K6 | 0.61598899 |
| 117 | BMPR1B | 0.61285157 |
| 118 | NLK | 0.59552790 |
| 119 | CDC42BPA | 0.59049425 |
| 120 | TGFBR2 | 0.58810904 |
| 121 | IRAK2 | 0.58728753 |
| 122 | STK38L | 0.56531464 |
| 123 | FGFR2 | 0.56231076 |
| 124 | DYRK2 | 0.55756399 |
| 125 | STK38 | 0.54252786 |
| 126 | TRPM7 | 0.52738832 |
| 127 | LATS2 | 0.52591359 |
| 128 | PTK2 | 0.52030608 |
| 129 | PAK3 | 0.51446280 |
| 130 | TAOK2 | 0.51148227 |
| 131 | MAP2K1 | 0.50802389 |
| 132 | MAPK4 | 0.48802204 |
| 133 | SGK223 | 0.48461834 |
| 134 | SGK494 | 0.48461834 |
| 135 | IRAK4 | 0.47405464 |
| 136 | PINK1 | 0.47273067 |
| 137 | MAPK12 | 0.47243570 |
| 138 | MAP3K14 | 0.46900577 |
| 139 | GSK3A | 0.45436434 |
| 140 | BRSK2 | 0.45209709 |
| 141 | CSNK1A1L | 0.45145304 |
| 142 | MATK | 0.44470378 |
| 143 | STK11 | 0.44077637 |
| 144 | PRKAA1 | 0.43933264 |
| 145 | PRKCZ | 0.43897412 |
| 146 | EPHB2 | 0.43869176 |
| 147 | ERBB2 | 0.43862105 |
| 148 | IKBKE | 0.42933510 |
| 149 | PRKCQ | 0.42392811 |
| 150 | MAPK7 | 0.42314740 |
| 151 | MST4 | 0.42145069 |
| 152 | PBK | 0.42141211 |
| 153 | ZAP70 | 0.42036382 |
| 154 | STK24 | 0.41741587 |
| 155 | CSF1R | 0.41561370 |
| 156 | LMTK2 | 0.39864963 |
| 157 | ABL1 | 0.39464964 |
| 158 | CDK7 | 0.38876823 |
| 159 | PDGFRB | 0.38364481 |
| 160 | MELK | 0.38363417 |
| 161 | MOS | 0.37610956 |
| 162 | PAK4 | 0.37286422 |
| 163 | GRK1 | 0.36991985 |
| 164 | CDK4 | 0.35759622 |
| 165 | PKN2 | 0.35646610 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.60829981 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.86609472 |
| 3 | Platelet activation_Homo sapiens_hsa04611 | 2.78200186 |
| 4 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.62067975 |
| 5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.43508025 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.38953831 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.38273634 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.35850688 |
| 9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.32677871 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.29072766 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.28864165 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.26580556 |
| 13 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.17826733 |
| 14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.17518396 |
| 15 | Histidine metabolism_Homo sapiens_hsa00340 | 2.13978465 |
| 16 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 2.09043895 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.07001726 |
| 18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.05919918 |
| 19 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.04575764 |
| 20 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.98633434 |
| 21 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.95440489 |
| 22 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.92059095 |
| 23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.91293011 |
| 24 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.85175546 |
| 25 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.84320396 |
| 26 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.76694642 |
| 27 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.74098440 |
| 28 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.71938552 |
| 29 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.71485597 |
| 30 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.70747815 |
| 31 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.68792643 |
| 32 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.66944691 |
| 33 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.66805250 |
| 34 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.66304983 |
| 35 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.65721626 |
| 36 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.61484261 |
| 37 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.59750529 |
| 38 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.59398412 |
| 39 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.56336321 |
| 40 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.55191919 |
| 41 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.54805359 |
| 42 | Tuberculosis_Homo sapiens_hsa05152 | 1.52879541 |
| 43 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.52331874 |
| 44 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.47952829 |
| 45 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.45643534 |
| 46 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.45246103 |
| 47 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.44636396 |
| 48 | Retinol metabolism_Homo sapiens_hsa00830 | 1.43025353 |
| 49 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.41888763 |
| 50 | Sulfur relay system_Homo sapiens_hsa04122 | 1.41665708 |
| 51 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.38115303 |
| 52 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.35373245 |
| 53 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.33388576 |
| 54 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.33297473 |
| 55 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.30757460 |
| 56 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.25232062 |
| 57 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.25109210 |
| 58 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.22835295 |
| 59 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.21475345 |
| 60 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.18175054 |
| 61 | Phagosome_Homo sapiens_hsa04145 | 1.17082189 |
| 62 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.15871019 |
| 63 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.14951689 |
| 64 | Endocytosis_Homo sapiens_hsa04144 | 1.12165674 |
| 65 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.11856336 |
| 66 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.10800700 |
| 67 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.10312753 |
| 68 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.09846841 |
| 69 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.09230225 |
| 70 | Measles_Homo sapiens_hsa05162 | 1.08312355 |
| 71 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.07846421 |
| 72 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.07790555 |
| 73 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.06401610 |
| 74 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.06365060 |
| 75 | Bile secretion_Homo sapiens_hsa04976 | 1.06126952 |
| 76 | Allograft rejection_Homo sapiens_hsa05330 | 1.05847400 |
| 77 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.05653738 |
| 78 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.05212961 |
| 79 | ABC transporters_Homo sapiens_hsa02010 | 1.05024822 |
| 80 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.04720206 |
| 81 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.01943300 |
| 82 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.01512645 |
| 83 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.00760001 |
| 84 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.99420326 |
| 85 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.99147577 |
| 86 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.98989222 |
| 87 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.98595537 |
| 88 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.97047449 |
| 89 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.95289961 |
| 90 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.95117802 |
| 91 | Carbon metabolism_Homo sapiens_hsa01200 | 0.94609912 |
| 92 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.93998678 |
| 93 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.92687716 |
| 94 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.90413172 |
| 95 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.90063622 |
| 96 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.88843893 |
| 97 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.87387605 |
| 98 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.85634529 |
| 99 | Endometrial cancer_Homo sapiens_hsa05213 | 0.85221454 |
| 100 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.85061858 |
| 101 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.84844509 |
| 102 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.84613772 |
| 103 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.83725973 |
| 104 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.81881393 |
| 105 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.79291167 |
| 106 | Influenza A_Homo sapiens_hsa05164 | 0.78090652 |
| 107 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.76814943 |
| 108 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.75942385 |
| 109 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.75176926 |
| 110 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.73319532 |
| 111 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.70870520 |
| 112 | Shigellosis_Homo sapiens_hsa05131 | 0.70698837 |
| 113 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.70379437 |
| 114 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67327334 |
| 115 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.66731109 |
| 116 | Viral myocarditis_Homo sapiens_hsa05416 | 0.66516420 |
| 117 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.66467607 |
| 118 | Other glycan degradation_Homo sapiens_hsa00511 | 0.65868842 |
| 119 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.65458344 |
| 120 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.64793825 |
| 121 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.63729366 |
| 122 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.63392103 |
| 123 | Long-term depression_Homo sapiens_hsa04730 | 0.62100743 |
| 124 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.62034576 |
| 125 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.61790909 |
| 126 | Lysine degradation_Homo sapiens_hsa00310 | 0.61061068 |
| 127 | Hepatitis B_Homo sapiens_hsa05161 | 0.59490413 |
| 128 | Amoebiasis_Homo sapiens_hsa05146 | 0.59368213 |
| 129 | Renin secretion_Homo sapiens_hsa04924 | 0.58254716 |
| 130 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.57381616 |
| 131 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.57190123 |
| 132 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.57138891 |
| 133 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.57103662 |
| 134 | Salmonella infection_Homo sapiens_hsa05132 | 0.56194000 |
| 135 | Metabolic pathways_Homo sapiens_hsa01100 | 0.55068776 |
| 136 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.55044567 |
| 137 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.54560436 |
| 138 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.54152172 |
| 139 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.53438554 |
| 140 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.52536202 |
| 141 | Gap junction_Homo sapiens_hsa04540 | 0.52411683 |
| 142 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.51531576 |
| 143 | Lysosome_Homo sapiens_hsa04142 | 0.50971323 |
| 144 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.50893377 |
| 145 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.48947177 |
| 146 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.48647267 |
| 147 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.48189248 |
| 148 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.46455796 |
| 149 | Mineral absorption_Homo sapiens_hsa04978 | 0.44779003 |
| 150 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.41825153 |
| 151 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.41231630 |
| 152 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.40832378 |
| 153 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.37817041 |
| 154 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.35586284 |
| 155 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.34452318 |
| 156 | Galactose metabolism_Homo sapiens_hsa00052 | 0.29226921 |
| 157 | Protein export_Homo sapiens_hsa03060 | 0.27718931 |
| 158 | Insulin resistance_Homo sapiens_hsa04931 | 0.19427535 |
| 159 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.19276906 |
| 160 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.17976651 |
| 161 | Hepatitis C_Homo sapiens_hsa05160 | 0.13202956 |
| 162 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.12664205 |
| 163 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.10531482 |
| 164 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.09634718 |
| 165 | Malaria_Homo sapiens_hsa05144 | 0.08599023 |
| 166 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.06205460 |
| 167 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.05537943 |
| 168 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.04578696 |
| 169 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.03819307 |
| 170 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.03791110 |
| 171 | Legionellosis_Homo sapiens_hsa05134 | 0.02671025 |
| 172 | Pertussis_Homo sapiens_hsa05133 | 0.01482564 |
| 173 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.01105125 |
| 174 | Leishmaniasis_Homo sapiens_hsa05140 | -0.0214562 |

